These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC, European Network for Vascular Disorders of the Liver. Hepatology; 2013 May; 57(5):1962-8. PubMed ID: 23389867 [Abstract] [Full Text] [Related]
13. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Attwell A, Ludkowski M, Nash R, Kugelmas M. Aliment Pharmacol Ther; 2004 Oct 15; 20(8):867-73. PubMed ID: 15479358 [Abstract] [Full Text] [Related]
14. [Budd-Chiari syndrome and TIPS--twelve years' experience]. Safka V, Hůlek P, Krajina A, Dulícek P, Fejfar T, Jirkovský V, Pozler O, Vańásek T. Cas Lek Cesk; 2005 Oct 15; 144 Suppl 3():38-42. PubMed ID: 16335262 [Abstract] [Full Text] [Related]
18. Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS. Dulíček P, Hůlek P, Krajina A, Renc O, Šafka V, Fejfar T, Sadílek P, Beránek M, Michiels JJ, Žák P. Int Angiol; 2016 Feb 17; 35(1):90-7. PubMed ID: 26138237 [Abstract] [Full Text] [Related]
19. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms. Potthoff A, Attia D, Pischke S, Mederacke I, Beutel G, Rifai K, Deterding K, Heiringhoff K, Klempnauer J, Strassburg CP, Manns MP, Bahr MJ. Liver Int; 2015 Aug 17; 35(8):2042-9. PubMed ID: 25736096 [Abstract] [Full Text] [Related]